Epoetin alfa biosimilar - BiosidusAlternative Names: Epoimmun™; Epoyet™; Hemax (Epoetin alfa); Hypercrit; Zyrop™
Latest Information Update: 20 Sep 2013
Price : $50
At a glance
- Originator Biosidus S.A.
- Class Antianaemics; Recombinant erythropoietins
- Mechanism of Action Erythropoietin receptor agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Anaemia
Most Recent Events
- 01 Jul 2013 Launched for Anaemia in China (SC)
- 29 Apr 2013 Launched for Anaemia in Thailand (SC)
- 07 Dec 2011 Launched for Anaemia in India (SC)